Loading stock data…
$1.03-0.07 (-5.91%)
IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally.
IceCure Medical Ltd in the Healthcare sector is trading at $1.03 with a market capitalization of $7M. Wall Street consensus targets $22.67 (3 analysts), implying a +2090.0% move over the next 12 months. The stock is currently near its 52-week low of $1.03, remaining 88.6% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 13 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $907,000↓ | $911,000↓ | $1.28M↑ | $850,000↑ | $525,000 |
| Gross Profit | $253,000↓ | $295,000↓ | $600,000↑ | $277,000↑ | $131,000 |
| Operating Income | -$4.42M↓ | -$4.25M↓ | -$4.22M↓ | -$3.84M↓ | -$3.38M |
| Net Income | -$4.50M↓ | -$4.27M↓ | -$4.25M↓ | -$3.86M↓ | -$3.36M |
IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and inte...